These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 7822017)

  • 21. Plasma levels of bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP) during hemodialysis.
    Schindler R; Marra MN; McKelligon BM; Lonnemann G; Schulzeck P; Schulze M; Oppermann M; Shaldon S
    Clin Nephrol; 1993 Dec; 40(6):346-51. PubMed ID: 7507806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An opsonic function of the neutrophil bactericidal/permeability-increasing protein depends on both its N- and C-terminal domains.
    Iovine NM; Elsbach P; Weiss J
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10973-8. PubMed ID: 9380744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The BPI/LBP family of proteins: a structural analysis of conserved regions.
    Beamer LJ; Carroll SF; Eisenberg D
    Protein Sci; 1998 Apr; 7(4):906-14. PubMed ID: 9568897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular identification and function analysis of bactericidal permeability-increasing protein/LPS-binding protein 1 (BPI/LBP1) from turbot (Scophthalmus maximus).
    Zhou S; Jiang G; Zhu Y; Liu L; Liu D; Diao J; Liu H; Xiu Y
    Fish Shellfish Immunol; 2019 Apr; 87():499-506. PubMed ID: 30731212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural requirements for intracellular processing and sorting of bactericidal/permeability-increasing protein (BPI): comparison with lipopolysaccharide-binding protein.
    Bülow E; Gullberg U; Olsson I
    J Leukoc Biol; 2000 Nov; 68(5):669-78. PubMed ID: 11073106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Separation of sublethal and lethal effects of the bactericidal/permeability increasing protein on Escherichia coli.
    Mannion BA; Weiss J; Elsbach P
    J Clin Invest; 1990 Mar; 85(3):853-60. PubMed ID: 2179269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein.
    Levy O; Martin S; Eichenwald E; Ganz T; Valore E; Carroll SF; Lee K; Goldmann D; Thorne GM
    Pediatrics; 1999 Dec; 104(6):1327-33. PubMed ID: 10585984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of lipopolysaccharide (LPS) chain length on interactions of bactericidal/permeability-increasing protein and its bioactive 23-kilodalton NH2-terminal fragment with isolated LPS and intact Proteus mirabilis and Escherichia coli.
    Capodici C; Chen S; Sidorczyk Z; Elsbach P; Weiss J
    Infect Immun; 1994 Jan; 62(1):259-65. PubMed ID: 8262637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antagonistic effects of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein on lipopolysaccharide-induced cytokine release by mononuclear phagocytes. Competition for binding to lipopolysaccharide.
    Dentener MA; Von Asmuth EJ; Francot GJ; Marra MN; Buurman WA
    J Immunol; 1993 Oct; 151(8):4258-65. PubMed ID: 8409400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of lipopolysaccharides in the action of the bactericidal/permeability-increasing neutrophil protein on the bacterial envelope.
    Weiss J; Muello K; Victor M; Elsbach P
    J Immunol; 1984 Jun; 132(6):3109-15. PubMed ID: 6373924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endotoxin-neutralizing properties of the 25 kD N-terminal fragment and a newly isolated 30 kD C-terminal fragment of the 55-60 kD bactericidal/permeability-increasing protein of human neutrophils.
    Ooi CE; Weiss J; Doerfler ME; Elsbach P
    J Exp Med; 1991 Sep; 174(3):649-55. PubMed ID: 1875165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP): structure, function and regulation in host defence against Gram-negative bacteria.
    Weiss J
    Biochem Soc Trans; 2003 Aug; 31(Pt 4):785-90. PubMed ID: 12887306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphisms in the lipopolysaccharide-binding protein and bactericidal/permeability-increasing protein in patients with myocardial infarction.
    Hubacek JA; Pitha J; Skodová Z; Adámková V; Podrapska I; Schmitz G; Poledne R
    Clin Chem Lab Med; 2002 Nov; 40(11):1097-100. PubMed ID: 12521224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of charge and hydrophobic interactions in the action of the bactericidal/permeability-increasing protein of neutrophils on gram-negative bacteria.
    Weiss J; Victor M; Elsbach P
    J Clin Invest; 1983 Mar; 71(3):540-9. PubMed ID: 6338040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant human bactericidal/permeability-increasing protein (rBPI23) is a universal lipopolysaccharide-binding ligand.
    Appelmelk BJ; An YQ; Thijs BG; MacLaren DM; de Graaff J
    Infect Immun; 1994 Aug; 62(8):3564-7. PubMed ID: 8039930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the bactericidal/permeability-increasing protein of polymorphonuclear leukocytes on isolated bacterial cytoplasmic membrane vesicles.
    in't Veld G; Mannion B; Weiss J; Elsbach P
    Infect Immun; 1988 May; 56(5):1203-8. PubMed ID: 3281903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effect of a recombinant amino-terminal fragment of bactericidal/permeability-increasing protein in experimental endotoxemia.
    Kohn FR; Ammons WS; Horwitz A; Grinna L; Theofan G; Weickmann J; Kung AH
    J Infect Dis; 1993 Nov; 168(5):1307-10. PubMed ID: 8228369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipopolysaccharide-Binding Protein and Bactericidal/Permeability-Increasing Protein in Lipid Metabolism and Cardiovascular Diseases.
    Yu Y; Song G
    Adv Exp Med Biol; 2020; 1276():27-35. PubMed ID: 32705592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of the response to bacterial lipopolysaccharide by endogenous and exogenous lipopolysaccharide binding proteins.
    Marra MN; Thornton MB; Snable JL; Leong S; Lane J; Wilde CG; Scott RW
    Blood Purif; 1993; 11(2):134-40. PubMed ID: 7506040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective effects of a recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in an animal model of gram-negative sepsis.
    Evans TJ; Carpenter A; Moyes D; Martin R; Cohen J
    J Infect Dis; 1995 Jan; 171(1):153-60. PubMed ID: 7798655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.